JAK inhibitor selectivity: new opportunities, better drugs?
Anniina Virtanen, Francesca Romana Spinelli, Jean Baptiste Telliez, John J. O’Shea, Olli Silvennoinen, Massimo Gadina
Topics & Concepts
Janus kinaseMedicineImmune systemCytokineTyrosine kinaseJanus kinase 2Tyrosine kinase 2Cancer researchPharmacologyImmunologyReceptorInternal medicinePlatelet-derived growth factor receptorGrowth factorCytokine Signaling Pathways and InteractionsMyeloproliferative Neoplasms: Diagnosis and TreatmentRheumatoid Arthritis Research and Therapies